Search Orphan Drug Designations and Approvals
-
Generic Name: | Benzeneacetamide, 2-[2-[2-[[2-methoxy-4-(1-methyl-4-piperidinyl)phenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]ethyl]- |
---|---|
Date Designated: | 05/18/2020 |
Orphan Designation: | Treatment of idiopathic pulmonary fibrosis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Amplia Therapeutics 55 Flemington Road Suite 226 North Melbourne, VIC Australia The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-